Senate clears first hurdle toward repeal of ACA
President Donald Trump said before winning the election that the Affordable Care Act was one of the top items to be eliminated when he took office. Read More »
Amegen secures major victory in patent infringement case
Biopharmaceutical company Amgen won a major victory in case involving the infringement of two patents held by the company. Read More »
Walgreens, Florida Hospital form coordinated care partnership
Florida Hospital and Walgreens have initiated a retail health clinic and pharmacy collaboration to focus on delivering coordinated care and providing greater access to patients across the Tampa region. Read More »
Almost half of U.S. consumers blame drug companies for high drug costs, according to new survey
A clear plurality (almost half) of American consumers blame drug makers for high drug costs, according to a new Google Consumer Survey conducted for American Pharmacy News. Read More »
Johnson & Johnson purchases Swiss biopharm company
Johnson & Johnson has bought the controlling shares of Switzerland-based Actelion, with an immediate finalization of the transaction. Read More »
Diabetes-related kidney failure rate drops drastically among Native Americans
The rate of kidney failure related to diabetes among Native American adults dropped more than 50 percent between 1996 and 2013, the Centers for Disease Control and Prevention reported recently. Read More »
Narcan nasal application receives FDA approval
The U.S. Food and Drug Administration has given approval for the use of Narcan, an emergency treatment medication to counteract heroin overdoses, in a nasal spray form. Read More »
Exparel pain reliever receives major endorsement
DePuy Synthes and Pacira Pharmaceuticals have entered into a partnership to promote pain reliever Exparel. Read More »
Linzess for constipation receives FDA approval
The U.S. Food and Drug Administration has approved Linzess, a treatment for people suffering with chronic idiopathic constipation. Read More »
FDA approves d-Methadone for clinical trials
Relmada Therapeutics, a biopharmaceutical company that specializes in developing treatments for central nervous system diseases, received approval from the U.S. Food and Drug Administration to advance a new therapy to clinical trials. Read More »
CTI BioPharma taps Metzger as its new CEO
CTI BioPharma Corp., a company that specializes in developing blood cancer treatments, has named Michael Metzger its new director. Read More »
FDA gives new Alzheimer's treatment fast-track designation
ABBV-8E 12 -- a new Alzheimer’s treatment still in development -- received a fast-track designation from the U.S. Food and Drug Administration to be moved to clinical trials. Read More »
Systech helps drug makers meet serialization deadline
Systech International's Serialized by November program helped numerous manufacturers comply with the standards outlined in the Drug Supply Chain Security Act before its deadline. Read More »
FDA issues new naming guidance for biologics, biosimilars
The U.S. Food and Drug Administration released its final guidance on naming biologics and biosimilars. Read More »
Former CMS head: PBMs driving down drug costs, 'price-fixing' won't work
As the Trump Administration and new Congress signal their intent to somehow deal with the issue of rising prescription drug prices, the notion of giving the federal government more power to negotiate drug prices in Medicare Part D has been suggested as one measure that might be implemented. Two leading experts this week, however, threw cold water on that proposal, noting that such negotiations already exist and serve to bring down drug costs. Read More »
MinuteClinic helps fill gap in women's health care
Access to affordable and dependable health care for women has become growing issue, and one facility says that it is prepared to play a big role in the solution in making women’s health care more accessible. Read More »
UnitedAg to host annual meeting in March
Blue Shield of California and OptumRX will co-sponsor agricultural trade organization UnitedAg's 37th Annual Meeting and Conference in Napa, California, March 14-17. Read More »
Xyzal Allergy approved for over-the-counter sales
Sanofi has received FDA approval of Xyzal Allergy 24HR, an over-the-counter option for those suffering with certain allergies. Read More »
Digital Pharmacist forged from merger of two companies
Digital Pharmacist Inc. was launched Jan. 31 after the strategic merger of TeleManager Technologies Inc. and RxWiki Inc. Read More »
Walgreens, Rite Aid decrease sale price by $2 billion
Walgreens Boots Alliance and Rite Aid recently came to an agreement on a price reduction for the purchase of Rite Aid. Read More »
Alerts Sign-up